Not applicableUnknownNCT04785833What this trial is testingCD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute LeukemiaWho this might be right forT-ALL PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Early research (Phase 1)UnknownNCT04007978What this trial is testingAnti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell MalignanciesWho this might be right forB Cell LymphomaAcute Lymphoblastic Leukemia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Early research (Phase 1)Study completedNCT01161550What this trial is testingCladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AMLWho this might be right forLeukemia, Myeloid, Acute Washington University School of Medicine 11
Early research (Phase 1)Study completedNCT00070538What this trial is testingVNP40101M and Cytarabine in Treating Patients With Hematologic MalignanciesWho this might be right forLeukemiaMyelodysplastic Syndromes Vion Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT03743246What this trial is testingEvaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)Who this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin Celgene 21
Early research (Phase 1)WithdrawnNCT05519527What this trial is testingSTI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisWho this might be right forRefractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML) M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00021242What this trial is testingDocetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 12
Testing effectiveness (Phase 2)Ended earlyNCT03922100What this trial is testingStudy of NMS-03592088 in Patients With Relapsed or Refractory AML or CMMLWho this might be right forAcute Myeloid Leukemia (AML)Chronic Myelomonocytic Leukemia (CMML) Nerviano Medical Sciences 63
Testing effectiveness (Phase 2)Study completedNCT00337168What this trial is testingS0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 36
Testing effectiveness (Phase 2)Looking for participantsNCT06481735What this trial is testingTCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALLWho this might be right forAcute Lymphocytic Leukemia Chinese PLA General Hospital 30
Early research (Phase 1)UnknownNCT03574168What this trial is testingCD19-CAR-T Cells in Patients With R/R B-ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Bioceltech Therapeutics, Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT05488132What this trial is testingAdministration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)Who this might be right forAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse Xuzhou Medical University 20
Early research (Phase 1)Study completedNCT01396499What this trial is testingStudy to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced LeukemiasWho this might be right forLeukemia M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT03544021What this trial is testingCART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）Who this might be right forLeukemia, Lymphocytic, Acute The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Testing effectiveness (Phase 2)Ended earlyNCT00818649What this trial is testingBortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndrome Masonic Cancer Center, University of Minnesota 16
Testing effectiveness (Phase 2)UnknownNCT05821738What this trial is testingAvapritinib in CBF-AML With KIT MutationsWho this might be right forCore Binding Factor Acute Myeloid LeukemiaKIT Mutation-Related Tumors The First Affiliated Hospital of Soochow University 50
Not applicableStudy completedNCT00060021What this trial is testingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell TransplantationWho this might be right forCancer National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821What this trial is testingFlu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 459
Early research (Phase 1)Study completedNCT03298516What this trial is testingDCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction ChemotherapyWho this might be right forLeukemia, Myeloid, Acute Genentech, Inc. 19
Not applicableLooking for participantsNCT06783816What this trial is testingA Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological TumorsWho this might be right forAcute Lymphocytic LeukemiaLymphoma,Non-HodgkinRelapsed Refractory Multiple Myeloma Shanxi Bethune Hospital 45